Irccs San Raffaele Roma S.r.l.
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Irccs San Raffaele Roma S.r.l. in Rome, clinical research in cardiovascular diseases focuses on chronic heart failure with reduced ejection fraction. The trials are designed to assess whether new treatment options can lower major heart-related risks and improve outcomes for patients living with this serious condition.
- Evaluating treatment effectiveness in chronic heart failure with reduced ejection fraction
- Studying ways to reduce cardiovascular death and heart failure hospitalization
This work reflects a strong interest in improving care for patients with advanced heart disease through better therapeutic strategies.
Nervous System Diseases
The site also supports research in nervous system diseases, with a focus on chronic migraine. These studies aim to determine whether new preventive approaches can reduce the number of monthly migraine days and ease the burden of frequent headaches in adults.
- Investigating prevention strategies for chronic migraine
- Measuring changes in monthly migraine days to understand treatment benefit
This area of research highlights the Neurology Department’s interest in improving symptom control and day-to-day quality of life for people with ongoing migraine disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 3 therapeutic areas and 15 of 27 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 11 by active trials.
lock +10 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Pfizer Inc.5trials
lock +5 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Irccs San Raffaele Roma S.r.l.
lock Showing 1 of 35 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A DOSE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM EFFICACY, SAFETY, AND TOLERABILITY OF UCB0599 IN STUDY PARTICIPANTS WITH PARKINSON’S DISEASE | UCB Biopharma | Phase II | Not Recruiting | Dec 2022 | Mar 2025 |
IMP list
lock Showing 1 of 27 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Rimegepant | 4 | Unknown | 2022-10-04 | 2025-10-17 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.